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Abstract. 
 
PDI1
 
 is the essential gene encoding protein
disulﬁde isomerase in yeast. The 
 
Saccharomyces cerevi-
siae
 
 genome, however, contains four other nonessential
genes with homology to 
 
PDI1
 
: 
 
MPD1
 
, 
 
MPD2
 
, 
 
EUG1
 
,
and 
 
EPS1
 
. We have investigated the effects of simulta-
neous deletions of these genes. In several cases, we
 
found that the ability of the 
 
PDI1
 
 homologues to restore
viability to a 
 
pdi1
 
-deleted strain when overexpressed
was dependent on the presence of low endogenous lev-
els of one or more of the other homologues. This shows
that the homologues are not functionally interchange-
able. In fact, 
 
Mpd1p
 
 was the only homologue capable of
carrying out all the essential functions of 
 
Pdi1p
 
. Fur-
thermore, the presence of endogenous homologues with
a CXXC motif in the thioredoxin-like domain is re-
 
quired for suppression of a 
 
pdi1
 
 deletion by 
 
EUG1
 
 (which
contains two CXXS active site motifs). This underlines
the essentiality of protein disulﬁde isomerase-catalyzed
oxidation. Most mutant combinations show defects in
carboxypeptidase Y folding as well as in glycan modiﬁ-
cation. There are, however, no signiﬁcant effects on ER-
associated protein degradation in the various protein
disulﬁde isomerase-deleted strains.
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Introduction
 
An important aspect of folding of secretory proteins is the
formation of native disulfide bonds, a process catalyzed by
protein disulfide isomerase (PDI)
 
1
 
 (Givol et al., 1995). In
the eukaryotic cell, the endoplasmic reticulum is the or-
ganelle where folding of secretory proteins occurs, and is
the location of PDI as well as other chaperones. PDI-like
proteins can be identified by one or more domains with se-
quence similarity to thioredoxin, a signal sequence, and
the presence of an ER retention signal, (K/H)DEL. Yeast
PDI (in this study, PDI is used as a more general term for
a PDI-like protein, while Pdi1p specifically refers to the
protein encoded by the yeast gene 
 
PDI1
 
), Pdi1p, contains
two thioredoxin-like domains with the active site sequence
motif CGHC that is found in the majority of eukaryotic
PDIs (Edman et al., 1985). The two cysteines are able to
cycle between a reduced and an oxidized state. In the lat-
ter state, the two cysteines form an intramolecular disul-
fide bond that in principle enables PDI to convert a pair of
sulfhydryl groups in a polypeptide substrate into a disul-
fide bond. Recently, the yeast protein Ero1p, has been
shown to be essential for thiol oxidation in the ER (Frand
and Kaiser, 1998; Pollard et al., 1998), and a pathway has
been proposed in which oxidizing equivalents flow from
Ero1p to Pdi1p and on to the substrate (Frand and Kaiser,
1999). Glutathione, which was previously thought to play
the major role in oxidation in the ER, probably acts more
as a reductant (Cuozzo and Kaiser, 1999).
In most organisms, a number of genes encoding PDI-like
 
proteins are found. In 
 
Escherichia coli
 
, at least four proteins
with thioredoxin-like domains have convincingly been
shown to be involved in various aspects of disulfide bond
formation and shuffling in the periplasm (Åslund and Beck-
with, 1999). In eukaryotes, the ER fulfills much the same
role as the bacterial periplasm. The number of putative
PDIs in the mammalian ER is even higher. However, a spe-
cific function has been suggested only for a limited number
of these proteins (Ferrari and Söling, 1999). One of the
PDI-like proteins that has received the most attention is
ERp57, which has been shown to be involved in the ER
quality control system. It interacts with calnexin/calreticulin
in binding glycoprotein folding intermediates. This activity
does not seem to depend on its oxidoreductase properties
(Oliver et al., 1997). A specific function is also likely for the
pancreatic PDI, PDIp, which is the only known PDI-like
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protein showing tissue--specific expression (Desilva et al.,
1996). The domain organization varies between the differ-
ent PDIs. For instance, the stress-induced protein ERp72
has three active thioredoxin-like proteins, as compared with
the two of Pdi1p (Dorner et al., 1990; Mazzarella et al.,
1990). ERp72 and other genes encoding mammalian PDIs
are able to suppress the lethal effects of deletion of 
 
PDI1
 
 in
yeast (Günther et al., 1993; Laboissière et al., 1995).
In 
 
Saccharomyces cerevisiae
 
, the complete genome se-
quence shows that the number of putative PDIs is most
likely limited to five, of which the 
 
PDI1 
 
gene is the only
essential gene (Farquhar et al., 1991). Overexpression of
any of the nonessential homologues 
 
EUG1
 
, 
 
MPD1
 
,
 
MPD2
 
, or 
 
EPS1
 
, however, has been found to suppress the
lethality caused by deletion of 
 
PDI1
 
 (Tachibana and
Stevens, 1992; Tachikawa et al., 1995, 1997; Wang and
Chang, 1999). Eug1p shows an overall sequence identity of
 
z
 
40% to Pdi1p and contains two thioredoxin-like do-
mains (Fig. 1). Unlike all known PDIs, the active sites of
Eug1p have a CXXS motif (Tachibana and Stevens, 1992).
Thus, the active sites of Eug1p are not able to form in-
tramolecular disulfide bonds. Therefore, Eug1p alone is
unable to carry oxidizing equivalents. 
 
MPD1
 
 and 
 
MPD2
 
encode proteins containing only a single thioredoxin-like
domain (Fig. 1). Apart from the thioredoxin domain, they
share no further sequence homology with any protein of
known function. Overexpression of 
 
EUG1
 
, 
 
MPD1
 
, or
 
MPD2
 
 does not fully complement a 
 
pdi1
 
 deletion since
such strains show a reduced folding rate of procarboxy-
peptidase Y (proCPY) (Tachibana and Stevens, 1992;
Tachikawa et al., 1995, 1997).
Recently, a novel PDI-like protein named Eps1p was
characterized. It contains a single thioredoxin-like domain
and is localized to the ER membrane (Fig. 1). It has been
proposed to be involved in ER quality control, as deletion
of the gene suppresses a dominant-negative 
 
pma1
 
 mutant.
 
PMA1
 
 encodes a plasma membrane proton ATPase, which
is essential for growth. The mutant in question prevents
wild-type Pma1p from being transported to the plasma
membrane. In a strain deleted for 
 
eps1
 
, both mutant and
 
wild-type Pma1p are transported to the plasma membrane,
thereby allowing growth (Wang and Chang, 1999).
In previous genetic analyses of 
 
pdi1
 
 complementation,
be it heterologous or homologous, the potential contribu-
tions from the Pdi1p homologues have been disregarded.
With the present work, we wish to determine the role of
the homologues in thiol oxidation and, in particular, to de-
termine how important these enzymes are when PDI ac-
tivity is compromised. To do this, we have constructed
yeast strains simultaneously deleted for two or more of
these genes. The success of this approach is illustrated by
the observation that a mutant form of Pdi1p, Pdi1p
 
CGHS-
CGHS
 
, (this nomenclature is adopted for describing the se-
quence of the two active sites of the protein; the sequence
of the more NH
 
2
 
-terminal active site is written first), which
is defective in oxidation, is dependent on an endogenous
homologue for its ability to complement the 
 
pdi1
 
 deletion.
We have also revealed differences in the functionality be-
tween the PDI-like proteins, as 
 
MPD1 
 
is the only 
 
PDI1
 
homologue that, when overexpressed, is able to suppress a
strain deleted for all genes of the 
 
PDI1
 
 family.
 
Materials and Methods
 
Media and Materials
 
Yeast cells were grown in standard YPD and SC media (Sherman, 1991).
 
E. coli
 
 was grown in LB medium supplemented with the appropriate anti-
biotic (Sambrook, 1989). Restriction enzymes, T4 DNA polymerase, T4
polynucleotide kinase, and T4 DNA ligase were from Promega. Oligonu-
cleotides were synthesized by DNA Technology (Aarhus). Sequencing
was performed using a 
 
Taq
 
 Dye DeoxyTM terminator cycle sequencing
kit on an API 373A DNA Sequencer, both from Applied Biosystems.
1,4-Dithiothreitol, 5-fluoro-orotic acid (5-FOA), and 
 
o
 
-nitrophenyl-
 
b
 
-
 
D
 
-galactoside (ONPG) were from Merck. 
 
N
 
-acetyl-
 
DL
 
-phenylala-
nine 
 
b
 
-naphtyl ester and calcofluor white were from Sigma-Aldrich.
4-acetamido-4
 
9
 
-maleimidylstilbene-2,2
 
9
 
-disulfonic acid (AMS) was from
Molecular Probes. [
 
35
 
S]Methionine was from DuPont.
 
Strains and Plasmids
 
All plasmids used in this study are listed in Table I. The yeast strains used
in this study are listed in Table II.
Figure 1. Yeast contains three genes that encode
soluble ER proteins with sequence homology to
Pdi1p. Open boxes indicate the position and ex-
tent of thioredoxin-like domains. Active-site cys-
teines and the amino acid residues between them
are shown. The protein Eug1p has z40% se-
quence identity to Pdi1p and contains, like
Pdi1p, two regions with sequence homology to
thioredoxin. MPD1 and MPD2 encode proteins
that are smaller than Pdi1p and Eug1p and con-
tain only one thioredoxin-like active site. The
protein Eps1p contains one thioredoxin-like re-
gion as well as a transmembrane domain (the
closed box marked TMD). 
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Deletion of the 
 
PDI1
 
 gene was described in Tachibana and Stevens
(1992). The 
 
EUG1
 
 gene was deleted with the plasmid pCT19, using the
“pop-in, pop-out” method (Rothstein, 1991). A 4.8-kb EcoRI-SalI frag-
ment of 
 
EUG1
 
 was inserted into the 
 
URA3
 
-based plasmid pRS306 (Sikor-
ski and Hieter, 1989). The HindIII-NruI fragment was subsequently de-
leted, resulting in plasmid pCT19, which was digested with SnaBI,
introduced into yeast, and integrated into the chromosome. Integrants
were spread on plates containing 5-FOA, which selects cells that have lost
the 
 
URA3 
 
gene. The desired pop-out results in a deletion of the HindIII-
NruI region of the 
 
EUG1
 
 locus. To confirm the correct pop-in, pop-out,
PCR was performed using the primers oCT3 (5
 
9
 
 CCA ACA GTA AAG
CAC TGT CC 3
 
9
 
) and oCT5 (5
 
9
 
 CCC CTG AAT CTA CTT CGG CG 3
 
9
 
).
Correct deletion of the 
 
EUG1
 
 gene resulted in a PCR product of 
 
z
 
330 bp.
The plasmid pPN196 is derived from pFA6-kanMX3 (Wach et al.,
1994) by exchanging the 
 
kan
 
r
 
 gene with the 
 
URA3
 
 gene. Two DNA
fragments (the HincII-HincII and the Eco47III-PvuII fragment from
pBH1800) with sequence identity to the 
 
MPD1
 
 gene were inserted into
pPN196 on each side of the 
 
URA3
 
 gene, resulting in the plasmid pPN330.
The fragment containing the 
 
URA3
 
 gene flanked by two direct repeats
and the regions homologous to the 
 
MPD1
 
 gene was excised from plasmid
pPN330 with SspI, introduced into yeast, and integrated into the chromo-
some. This leads to deletion of base pairs 101–387 of the 
 
MPD1
 
 ORF.
Cells that had lost 
 
URA3 
 
were selected by plating the integrants on me-
dium containing 5-FOA. To confirm the correct deletion of 
 
MPD1
 
, PCR
was performed using oPN13 (5
 
9
 
 CCT TGC GAG GCG TAT AAA 3
 
9
 
)
and oBH64 (5
 
9
 
 CCT GAG TAC ACT TCA TTG GC 3
 
9
 
). The desired de-
letion gave a PCR product of 
 
z
 
700 bp.
The vector pFA6-kanMX3 (Wach et al., 1994) was used as template in a
PCR reaction using the primers oLA4 (5
 
9
 
 CAC AGC GAG TCT AGT
GCA AGT ACG TCG GCA AAG TAA AAC ACA AAG GAG ATG
GGA TCC CCG GGT TAA TTA AGG CGC 3
 
9
 
) and oLA5 (5
 
9
 
 CGT
CTG TAG TCG GTA TTC GTA AAG TAA AAG ACA GAG CGA
AGC TTA TGT TCA CTG ATA TCA TCG ATG AAT TCG AGC 3
 
9
 
).
This resulted in a fragment containing the 
 
kan
 
r
 
 gene flanked by two direct
repeats and two 
 
MPD2
 
 fragments represented by the oligonucleotides. The
fragment was integrated into the chromosome and correct substitution was
confirmed by PCR using the primers oLA1 (5
 
9
 
 GGT CAA CGG GAA
TGA GGG GAA 3
 
9
 
) and oLA8 (5
 
9
 
 CCC ATA TAA ATC AGC ATC C
3
 
9
 
). The desired deletion of the 
 
MPD2
 
 gene gave a PCR product of 
 
z
 
1,480
bp. The mating type of the 
 
MPD2
 
 deleted strain was changed from 
 
a
 
 to 
 
a
 
by crossing to an isogenic strain. This strain was subsequently crossed with
a 
 
D
 
pdi1 
 
D
 
eug1 
 
[PDI1] strain (
 
D
 
pdi1
 
 
 
D
 
eug1
 
 [PDI1] denotes a yeast strain de-
leted for 
 
PDI1
 
 and 
 
EUG1
 
 and complemented by 
 
PDI1
 
 on a plasmid).
The 
 
EPS1
 
 gene was amplified by PCR using the primers oBH61 (5
 
9
 
CGC GGA TCC GCG CAA GAA ATT CTA TCC AGG 3
 
9
 
) and oBH62
(5
 
9
 
 TCC CCG CGG GGA TTT TTA TGG TAG GCG TGC 3
 
9
 
), and the
PCR product was cloned into the EcoRV site of pBCSK
 
1
 
 (Stratagene).
The SalI-XhoI and EcoRV-EcoRV fragments of a plasmid containing the
 
EPS1
 
 ORF were inserted into the SalI and SmaI sites, respectively, of
YDp-L (Berben et al., 1991). The resulting plasmid, pPN100, was digested
with SphI and SalI, and the fragment containing the 
 
LEU2
 
 gene flanked
by regions homologous to 
 
EPS1
 
 was integrated into the chromosome
leading to deletion of base pairs 499–978 of the ORF of 
 
EPS1
 
. To confirm
correct integration, PCR was performed using the primers oPN006 (5
 
9
 
AGC GGA AAT AGG TGC GAA 3
 
9
 
) and oPN012 (5
 
9
 
 AAC AGT ACC
ACC GAA GTC 3
 
9
 
). The desired deletion of 
 
EPS1 resulted in a PCR
product of z800 bp.
Of the plasmids listed in Table I, pBH1464, pBH1711, pBH1857,
pBH1966, and pCT58 have been described elsewhere (Holst et al., 1997).
pBH1865 was constructed by subcloning a BamHI-NaeI fragment from
pCT40 (Tachibana and Stevens, 1992) into the corresponding sites of
pBH1692 (Holst et al., 1997). pCT38 is derived from pRS316 and contains
a 2.6-kb KpnI-XbaI fragment extending from 879-bp upstream of the
PDI1 gene to 160-bp downstream of PDI1.
MPD1 and MPD2 used to construct the plasmids for complementation
were amplified by PCR from yeast chromosomal DNA. MPD1 was ampli-
fied using the oligonucleotides oBH57 (59 CGC GGA TCC GCG TCC
ACT TAA CAC AAT TAG G 39) and oBH58 (59 TCC CCG CGG GGA
CTT ATT CTT ATG CCC C 39) as primers, which introduced a BamHI
site upstream of the ORF and a SacII site downstream of MPD1, respec-
tively. After digestion with BamHI and SacII, the PCR-amplified frag-
ment was inserted between the corresponding sites of pBH1692, resulting
in plasmid pBH1800. The sequence of the cloned ORF was found to be
identical to the published sequence, except for a silent C to T mutation at
nucleotide position 1168 relative to the ATG codon. MPD2 was ampli-
fied using the oligonucleotides oBH59 (59 CGC GGA TCC GCG GCG
AGT CTA GTG CAA GTA CG 39) and oBH60 (59 TCC CCG CGG
GGA CTT ATA TTG CGG CTA ACG 39). The use of oBH59 and
oBH60 also introduced a BamHI site upstream and a SacII site down-
stream, respectively, of the ORF. After digestion with BamHI and SacII,
the PCR-amplified fragment was inserted between the corresponding sites
of pBH1692, giving pBH1806. The sequence of the cloned ORF was found
to be identical to the published sequence.
The genes encoding the Pdi1p homologues were introduced via a plas-
mid shuffle procedure (Sikorski and Boeke, 1991). The TRP1-containing
plasmids were introduced into the desired strains carrying PDI1 on a
URA3-based plasmid. Clones lacking the plasmid carrying PDI1 were se-
lected on medium containing 5-FOA.
Table I. Plasmids Used
Name Gene* Marker Source
Plasmids used for complementation‡
pCT38 PDI1 URA3 This study
pCT58 EUG1CLHC-CIHC TRP1 Holst et al., 1997
pBH1464 PDI1 TRP1 Holst et al., 1997
pBH1711 PDI1CRRC-SGHS TRP1 Holst et al., 1997
pBH1800 MPD1 TRP1 This study
pBH1806 MPD2 TRP1 This study
pBH1857 PDI1 TRP1 Holst et al., 1997
pBH1865 EUG1 TRP1 This study
pBH1966 PDI1CGHS-CGHS TRP1 Holst et al., 1997
Used for
Plasmids used for deletion of genes
pCT19 Deletion of EUG1 This study
pPN100 Deletion of EPS1 This study
pPN330 Deletion of MPD1 This study
pFA6-kanMX3 Deletion of MPD2 Wach et al., 1994
Promoter
Plasmids containing promoter-lacZ fusions
pPN379 MPD1 promoter This study
pPN382 MPD2 promoter This study
pPN410 PDI1 promoter This study
pPN575 EUG1 promoter This study
*In all cases, the gene is placed under control of the PDI1 promoter. 
‡All self-replicating plasmids listed are centromere based and are therefore present at
a low copy number.
Table II. Yeast Strains
Name Chromosomal deletions Plasmid Source
M 4129 — —
Tachibana and 
Stevens, 1992
M 4426 eug1 — This study
M 4427 mpd1 — This study
M 4419 mpd2  — This study
M 4360 eps1 — This study
M 4174 pdi1 pCT38 Tachibana and 
Stevens, 1992
M 4741 ero1-1 pdi1 pCT38 This study
M 4172 pdi1 eug1 pCT38 This study
M 4496 pdi1 mpd1 pCT38 This study
M 4418 pdi1 mpd2 pCT38 This study
M 4837 mpd1 mpd2 eug1 eps1 — This study
M 4497 pdi1 eug1 mpd1 pCT38 This study
M 4417 pdi1 eug1 mpd2 pCT38 This study
M 4508 pdi1 mpd1 mpd2 pCT38 This study
M 4478 pdi1 eug1 mpd1 mpd2 pCT38 This study
M 4477 pdi1 eug1 mpd1 mpd2 eps1 pCT38 This study
All strains are isogenic with W303 MATa ade2-1 can1-100 ura3-1 leu2-3,112 trp1-1
his3-11,15 (Kurjan, 1985).The Journal of Cell Biology, Volume 152, 2001 556
pPN379 contains 1,500 base pairs of the MPD1 promoter fused to lacZ.
A PCR product, made using the primers oPN25 (59 ACG CGC GGA
TCC ACA GTC TTA GGG AAG TAA CC 39) and oPN26 (59 ACG
ACG GGA TCC ATT ATA TGT CAA ATT TTG TCT CTC C 39), was
digested with BamHI and inserted into the corresponding site of pFN8
(Nagawa and Fink, 1985). The plasmid pPN382 contains 1,500 base pairs
of the MPD2 promoter fused to lacZ. A PCR product, made using the
primers oPN27 (59 ACG CGC GGA TCC GAA GCC TGA GTT CAT
GCC CG 39) and oPN28 (59 ACG ACG GGA TCC ATC TCC TTT GTG
TTT TAC 39), was digested with BamHI and cloned into the correspond-
ing site of pFN8. The primers oVW201 (59 CGT CAG CTG AGG ATC
CGG TAC CAC CCA GG 39) and oVW202 (59 TAG CTG ACT GGG
ATC CTT CAT AAC GGG 39) were used to make plasmid pPN410,
which contains 880 base pairs of the PDI1 promoter fused to the lacZ
gene. The plasmid pPN575, containing 268 base pairs of the EUG1 pro-
moter, was made by cloning a PCR product from the primers oPN48 (59
ACG CGC GGA TCC AGT CAT CCT CTG ATT AAC TTT CC 39) and
oPN49 (59 ACG ACG GGA TCC ATG GTA TTA TAT GAG CGG G
39). The BamHI-digested PCR product was cloned into BamHI-digested
pFN8.
Pulse Labeling and Immunoprecipitation
The pulse-chase and immunoprecipitation experiments were carried out
essentially as described by Horazdovsky and Emr (1993). Yeast strains
that were Dprc1 were made PRC1 by integration of the wild-type allele of
PRC1 using the plasmid pIPRC. This plasmid is an EcoRI shrink of
pTSY3 (Stevens et al., 1986). Digestion with SacI facilitates integration
into the chromosome. The transformed yeast strains were tested for their
PRC11 phenotype by testing for CPY activity using an N-acetyl-DL-phe-
nylalanine b-naphtyl ester overlay assay (Jones, 1977). Strains were made
Dprc1::HIS3 using the plasmid described in Blachly-Dyson and Stevens
(1987). The prc1-1 allele encoding CPY* was introduced on the CEN-
URA3 plasmid pHIT341, a gift from R. Hitt and D. Wolf (Institut für Bio-
chemie, Universität Stuttgart, Stuttgart, Germany).
For Western blots, the cells (z4 OD600 of cells per sample) were col-
lected by centrifugation and resuspended in 5% (wt/vol) TCA. After cen-
trifugation, the pellet was washed twice in 100% acetone and subse-
quently resuspended in 100 ml of lysis buffer (100 mM MOPS, pH 7.0, 2%
SDS) containing 20 mM AMS to modify free thiols. Also, a protease in-
hibitor cocktail (Boehringer) was included, according to the supplier’s in-
structions. Approximately 50 ml of acid-washed glass beads (212–300 mm;
Sigma-Aldrich) were added to each sample. The samples were then vor-
texed for 30 min in an Eppendorf Mixer 5432 at room temperature, and
incubated for a further 30 min at room temperature to complete the sulf-
hydryl modification. CPY was subsequently immunoprecipitated as de-
scribed by Horazdovsky and Emr (1993). Horseradish peroxidase blots
were developed using ECL1 substrate (Amersham Pharmacia Biotech),
and scanned using Storm system image analysis (Molecular Dynamics).
Growth Phenotypes
Cultures grown overnight in SC 1 53Leu 1 53Ade were diluted to a
concentration of z5,000 cells/ml (53Leu or 53Ade denotes five times of
the normal SC concentration of the compound). 20 ml were applied on
SC 1 53Leu 1 53Ade plates. The plates were incubated for 2 d at 308C
before being photographed. The ability of yeast strains to grow in the
presence of DTT was determined by spotting cells in the same way onto
freshly prepared SC 1 53Leu 1 53Ade plates buffered to pH 5 and con-
taining 0–2.5 mM DTT. The plates were subsequently incubated in a CO2
atmosphere to minimize air oxidation of DTT. After 2 d at 308C, the
plates were photographed.
Measurement of b-Galactosidase Activity
b-galactosidase assays were performed using a protocol modified from
Guarente (1983). For preparation of the cell suspension, an overnight cul-
ture was diluted to a OD600 of z0.1 in a total volume of 25 ml in 100-ml
flasks. The culture was grown at 308C until an OD600 z 0.3. An appropri-
ate amount of culture was harvested by centrifugation and the pellet was
resuspended in 450 ml buffer Z (Guarente, 1983) containing 0.01% Triton
X-100. The solution was transferred to a 2-ml Eppendorf tube and the old
tube was washed with another 450 ml buffer Z 1 Triton X-100. The cell
suspension was vortexed for 10 s and immediately frozen in dry ice/etha-
nol before storage overnight at 2808C. For the assay, the cell suspension
was thawed, centrifuged at 10,000 g for 10 min to collect the cells. For each
assay, 950 ml buffer Z and 200 ml ONPG (from 4 mg/ml stock) were
mixed. 575 ml of buffer Z/ONPG mixture was added to the cells and vor-
texed for 5 s. Another 575 ml of buffer Z/ONPG mixture was added and
vortexed. After incubation at 308C, the assay was stopped by addition of
500 ml 1 M Na2CO3. The activity is calculated as described by Guarente
(1983). Each result is the mean 6 SEM of the data resulting from two in-
dependent transformants each measured five times.
Results
MPD1 Is the Only PDI1 Homologue that, on Its Own, Is 
Able to Ensure Cell Viability
From combined in vivo and in silico analysis, five genes
can be identified as being members of or obvious candi-
dates for the PDI family: PDI1, EUG1, MPD1, MPD2,
and EPS1 (Tachibana and Stevens, 1992; Tachikawa et
al., 1995, 1997; Wang and Chang, 1999). Of these genes,
PDI1 stands out as being the only essential gene. All
nonessential PDI1 homologues have been shown to be
multicopy suppressors of a pdi1 deletion. Thus, these
proteins, in principle, have the ability to carry out the
minimum Pdi1p function necessary for cell survival, but
they are either present in too low amounts and/or do not
have the necessary catalytic potency when produced at
normal levels.
We were interested in studying why yeast and other eu-
karyotes are equipped with such an array of PDI-like pro-
teins. More specifically, we wished to uncover putative
synthetic phenotypes by systematic disruption of several
PDI1 homologues in the same cell, and to investigate
each homologue’s effectiveness in suppression of a pdi1
deletion when expressed at roughly the same levels as
Pdi1p. To do so, we constructed null mutations of PDI1
EUG1, MPD1, MPD2, and EPS1, alone and in combina-
tions. The first important result of this experiment is that
simultaneous deletion of all four Pdi1p homologues
causes no obvious growth defect on synthetic complete
medium under normal laboratory conditions. Thus, no
synthetic phenotypes are displayed as long as PDI1 is
present. We then placed the MPD1, MPD2, EUG1, and
EPS1 open reading frames under the control of the PDI1
promoter on a low-copy TRP1-based plasmid. These plas-
mids were introduced into a Dpdi1 strain carrying PDI1
on a URA3-based plasmid. Growth on 5-FOA, which se-
lects for loss of the PDI1-containing URA3-based plas-
mid, was used as a measure of the ability of a gene to sup-
press the PDI1 deletion. The result is that Eug1p, Mpd1p,
and Mpd2p are all able to replace Pdi1p when produced
Figure 2. Growth of PDI-deficient yeast strains overexpressing
PDI1 homologues. Cell cultures were diluted, applied to SC 1
53Leu 1 53Ade plates and incubated at 308C for 2 d. The wild-
type growth rate (defined as the reciprocal of the doubling time) was
z0.7 h21 in SC medium, while the most extreme reduction in growth
rate was seen for a Dpdi1 [EUG1] strain (z0.3 h21; data not shown).Nørgaard et al. Yeast PD1 Homologues 557
to roughly the same level. However, their effectiveness at
doing so varies greatly. A Dpdi1 strain complemented by
MPD1 under control of the PDI1 promoter (Dpdi1
[MPD1]) showed a small reduction in growth rate com-
pared with the wild type, while the Dpdi1 [MPD2] and
Dpdi1 [EUG1] strains showed larger reductions in growth
rates (Fig. 2). We next wanted to see whether the ability
of these plasmids to complement the pdi1 deletion was
dependent on chromosomal copies of the other PDI1 ho-
mologues, or whether synthetic effects could be revealed.
This was accomplished by shuffling the various plasmids
containing the homologues into strains containing a pdi1
deletion in combination with deletions of the homo-
logues. The pattern of viability in this array of strains did
reveal functional differences between the MPD1, MPD2,
and EUG1 gene products (Table III). Deletion of EUG1
affected neither viability nor growth rate in any of the
yeast strains investigated. Overexpression of EUG1, on
the other hand, was able to complement the pdi1 deletion
only if MPD1 and MPD2 were both present. Differences
in the functionality of Mpd1p and Mpd2p were seen, as
overexpression of MPD2 was no longer able to rescue a
pdi1 deletion if MPD1 was also deleted, while overex-
pression of MPD1 rescued all strains. Not even expres-
sion of MPD2 from a high-copy plasmid rescued a pdi1
deletion in the absence of MPD1. The difference could, in
principle, reflect very low steady state levels of Mpd2p
compared with Mpd1p, caused by differences in protein
stability. To test this, we constructed plasmids containing
MPD1 and MPD2, in which the sequence encoding a
COOH-terminal myc-tag followed by the ER retention
signal HDEL were added. Both constructs were found to
phenocopy the wild-type genes in their ability to comple-
ment a pdi1-deleted strain. A Western blot of extracts
from these strains probed with myc-antibodies shows that
Mpd2p-myc is present at roughly the same level as
Mpd1p-myc when both tagged genes are expressed under
the control of the PDI1-promoter (data not shown). This
indicates that in a strain completely depleted of other
Pdi1p-like proteins, Mpd1p is the only homologue able to
provide all Pdi1p functions required for survival.
EPS1 was not able to rescue a pdi1-deleted strain when
expressed under control of the PDI1-promoter. It has pre-
viously been shown, however, that it can complement,
when expressed from a 2 mm plasmid (Wang and Chang,
1999). Since Eps1p may have a specialized role in ER
quality control, we did not pursue the investigation of this
protein.
The importance of the oxidizing CXXC motif was
shown with specific EUG1 and PDI1 mutants. Mutation of
the active sites of Eug1p to CXXC converts Eug1p to a
more Pdi1p-like enzyme as judged by its improved ability
to rescue a Dpdi1 strain (Holst et al., 1997). We found that
overexpression of the corresponding gene EUG1CLHC-CIHC
was able to rescue the simultaneous deletion of PDI1,
MPD1, MPD2, EUG1, and EPS1 (Table III). Conversely,
mutation of the active sites of Pdi1p to the more Eug1p-
like sequence CXXS restricted the ability of the gene to
rescue a pdi1 deletion to situations where MPD2 was
present (Table III). This might reflect a higher oxidative
capacity of Mpd2p than Mpd1p.
The protein Ero1p is required for ER oxidation of pro-
tein thiols (Frand and Kaiser, 1998; Pollard et al., 1998). It
has been shown that when a mutant form of Mpd2p con-
taining a CQHC-to-CQHA active site mutation is overex-
pressed, mixed disulfides with Ero1p can be trapped
(Frand and Kaiser, 1999). We wanted to test whether
Ero1p is involved in delivering oxidizing equivalents not
only to Pdi1p and Mpd2p, but also to Mpd1. To address
this question, we crossed a pdi1-deleted strain with the
temperature-sensitive ero1-1 mutant. If redox equivalents
passed only through Pdi1p, while a second pathway was
used when one of the homologues was overexpressed, no
synthetic phenotype would be observed. However, in the
double mutant, none of the homologues was able to rescue
the  pdi1 deletion when expressed under control of the
PDI1 promoter. The simplest explanation for this result is
that Ero1p is also able to transfer oxidizing equivalents to
the homologues.
Table III. Rescue of PDI Deficiencies by Overexpression of PDI Homologues
Introduced gene*
Yeast strain
Dpdi1
Dpdi1
Deug1
Dpdi1
Dmpd1
Dpdi1
Dmpd2
Dpdi1
Deug1
Dmpd1
Dpdi1
Deug1
Dmpd2
Dpdi1
Dmpd1
Dmpd2
Dpdi1
Deug1
Dmpd1
Dmpd2
Dpdi1
Deug1
Dmpd1
Dmpd2
Deps1
PDI1 11 11 11 11 11 11 11 11 11
EUG1 1 12222222
MPD1 1 11111111
MPD2 1 12121222
PDI1CRRC-SGHS 11 11 11 11 11 11 11 11 11
EUG1CLHC-CIHC 11 11 11 11 11 11 11 11 11
PDI1CGHS-CGHS 1 11212222
11, viable strain with near wild-type growth. 1, viable strain with a reduced growth rate compared with a wild-type strain. 2, viable strain could not be obtained. Overexpres-
sion of PDI1 and MPD1 rescues all strains, while overexpression of MPD2 only rescues strains containing MPD1. Furthermore, rescue by overexpression of EUG1 requires the
presence of both MPD1 and MPD2. The gene encoding a PDI-like mutant form of Eug1p, EUG1CLHC-CIHC, rescues all strains, while the gene encoding a Eug1p-like form of PDI,
PDI1CGHS-CGHS, is not able to rescue when MPD2 is deleted. 
*The gene was under control of the PDI1 promoter and was introduced on a low-copy number plasmid.
Table IV. Expression Levels
Promoter b-Galactosidase activity
Miller units
MPD2 0.0466 6 0.0038
MPD1 0.972 6 0.076
EUG1 1.173 6 0.056
PDI1 26.28 6 2.34The Journal of Cell Biology, Volume 152, 2001 558
The PDI1 Homologues Are Expressed at a Much Lower 
Level than PDI1
Since the PDI1 homologues are able to complement the pdi1
deletion only when expressed under control of the PDI1 pro-
moter, their normal levels are likely to be substantially lower
than that of the PDI1 gene. To estimate expression levels, we
measured the b-galactosidase activity from reporter con-
structs in which the promoter regions of all the genes in ques-
tion were fused to lacZ. In an otherwise wild-type yeast, the
b-galactosidase activity obtained from the MPD1 and EUG1
reporters were 4–5% of the activity from the PDI1-lacZ re-
porter, while that of the MPD2-lacZ reporter was only 0.2%
(Table IV). This indicates that the homologous proteins are
present at a much lower concentration than Pdi1p.
The question was posed as to whether the inability of
MPD1 to complement a pdi1 deletion is due only to the nor-
mally low abundance of the gene product or whether it also
is a consequence of reduced catalytic potency compared
with Pdi1p. To test this, we placed PDI1 under control of
the weak MPD1 promoter. Interestingly, such a plasmid was
able to rescue a strain simultaneously deleted for pdi1, eug1,
mpd1, mpd2, and eps1 (data not shown). This shows that it is
not only the lower expression levels of the PDI1 homo-
logues that make them incapable of fulfilling PDI function.
The Effects of Mutations in PDI1 Are Enhanced in 
Strains Lacking Pdi1p Homologues
DTT sensitivity is closely linked to the effectiveness of the
oxidizing apparatus of the ER (Jämsä et al., 1994; Frand
and Kaiser, 1998). DTT penetrates the ER and interferes
with the formation of disulfide bonds in nascent proteins
(Braakman et al., 1991). Mutants of Pdi1p mutated at the
two central residues of the active site CGHC sequence fur-
thermore show increased DTT sensitivity (Holst et al.,
1997). We were interested in determining to what extent
the oxidizing apparatus of the various deletion mutants
was affected. A wild-type strain is able to grow in the pres-
ence of 5 mM DTT under otherwise normal conditions. To
amplify possible differences in DTT sensitivity with re-
spect to growth, we used the mutant PDI1CRRC-SGHS, which
had previously been shown to cause increased sensitivity
towards DTT (Holst et al., 1997). We found that deletion
of all genes encoding the PDI homologues increased the
DTT sensitivity of the strain rescued by the mutant gene
PDI1CRRC-SGHS, most clearly seen by the difference in
growth at 0.5 and 1.0 mM DTT (Fig. 3).
The rate of intracellular folding of proCPY can be mon-
itored, as only folded proteins are allowed to exit the ER
(Gething et al., 1986). Since proCPY is converted to forms
of different molecular mass as it traverses the different
compartments of the secretory pathway, the rate of ER
exit can be determined (Stevens et al., 1982). Upon trans-
location into the ER, the protein receives four core N-gly-
cosyl residues, resulting in the 67-kD ER form of proCPY
called p1. The carbohydrate structure is further modified
in the Golgi, giving the 69-kD p2 form. Finally, when
proCPY reaches the vacuole, the propeptide is cleaved
off, resulting in the 63-kD mature, active form of CPY
(Stevens et al., 1982).
We followed the maturation of proCPY to CPY in
strains depleted for PDIs. Cells were labeled with [35S]me-
thionine for 15 min and chased for 0, 15, and 60 min. After
immunoprecipitation with CPY antibody, the samples
were subjected to SDS-PAGE and analyzed using a Phos-
phorImager. As seen in Fig. 4 A, the rate of proCPY fold-
ing was strongly dependent on the gene that was used to
rescue the pdi1 deletion. The half-time of proCPY mat-
uration in the PDI1-complemented strain is 5–10 min,
whereas the half time increased to z30 min in strains res-
cued by overexpression of MPD1. When the pdi1 deletion
is rescued by overexpression of EUG1, proCPY mat-
uration is almost arrested, accompanied by accumulation
of the p1 ER form of proCPY. This effect is even more
pronounced in the strain rescued by overexpression of
MPD2. Deletion of the genes encoding the various homo-
logues had no, or very little, effect on the rate of proCPY
maturation as long as the strains were complemented by
PDI1 (Fig. 4 B), indicating that the Pdi1p homologues do
not normally make a significant contribution to proCPY
folding. However, the homologues do recognize proCPY
as a substrate in the absence of Pdi1p, because maturation
of proCPY takes place, although at a reduced rate.
As Eug1p is not on its own able to carry out oxidation
reactions, oxidation should be less efficient in a Dpdi1
strain complemented by EUG1. We tested this assumption
by looking at the redox state of proCPY under steady
state. Extracts were made in the presence or absence of
the thiol modifying agent AMS. AMS modifies free sulfhy-
dryl groups only, and the modification causes a mobility
shift on SDS-PAGE due to the bulkiness of the AMS
group. The cell extracts were separated on an SDS-PAGE,
blotted onto a nitrocellulose membrane, and probed with
CPY antibodies. As seen in Fig. 5 A, proCPY in a wild-
type strain is not modified by AMS, while treatment of the
Figure 3. DTT sensitivity of PDI-deficient yeast strains overex-
pressing PDI1 homologues. Cultures were diluted and applied to
SC  1  53Leu  1  53Ade plates buffered to pH 5 and supple-
mented with different concentrations of DTT. To prevent oxida-
tion of DTT by molecular oxygen, the plates were freshly made
and incubated at 308C in a CO2 atmosphere.Nørgaard et al. Yeast PD1 Homologues 559
cells with DTT before the AMS modification causes a
large mobility shift on the gel. This corresponds to modifi-
cation of all eleven cysteines in the fully reduced proCPY.
proCPY in the Dpdi1 [EUG1] strain is partially AMS
modifiable, suggesting that a significant portion of the
proCPY is not completely oxidized at steady state. This in-
dicates that oxidation is in fact compromised in the EUG1
complemented strain.
Pdi1p Depletion Affects Protein Glycosylation
In the Dpdi1 [EUG1], the Dpdi1 [MPD2], and the Dpdi1
Deug1 Dmpd1 Dmpd2 Deps1 [MPD1] strains, the p1 and
the p2 forms of proCPY are not fully separated (Fig. 4, A
and B). The p1 form in these strains appears to migrate
slower than wild type. Also, the mature form of CPY
shows a faster mobility than in the wild-type strain. That
these differences in mobility originate from glycosylation
defects is confirmed by their disappearance upon treat-
ment of the samples with endoglycosidase H (data not
shown). Since the p1 form migrates slower (most clearly
seen in Fig. 5 B), this defect must originate in the ER.
The compound calcofluor white interferes with cell wall
assembly, and hypersensitivity towards this compound has
therefore been used to indicate defects in cell-wall biogen-
esis. Several mutants showing hypersensitivity towards cal-
cofluor white are affected in enzymes involved in the gly-
cosylation apparatus (Ram et al., 1994; Lussier et al., 1997).
Consistent with the observed glycosylation defects was the
finding that the Dpdi1 [EUG1], the Dpdi1 [MPD2], and
the Dpdi1 Deug1 Dmpd1 Dmpd2 Deps1 [MPD1] strains all
were extremely sensitive towards calcofluor white (data
not shown).
Pdi1p Homologues Play No Significant Role in
ER-associated Degradation
PDI-like proteins have been implicated in quality control
and ER-associated degradation of misfolded ER proteins
(Oliver et al., 1997; Gillece et al., 1999; Wang and Chang,
1999). In yeast, Pdi1p has been shown to play a role in deg-
radation via the ubiquitin-proteasome pathway (ERAD)
of two model substrates: an unglycosylated mutant form of
prepro-a-factor and CPY with a single amino acid muta-
tion, CPY* (Gillece et al., 1999). The degradation of the
former appeared to be independent of disulfide chemistry,
but rather involved a putative peptide-binding domain of
Pdi1p. CPY* degradation on the other hand appeared to
be dependent on Pdi1p activity, but not the binding do-
main. As it was suggested that other additional compo-
nents might be involved, we wished to investigate whether
any of the Pdi1p homologues played a role. We found that
the homologues were not important for efficient degrada-
tion of CPY*, as demonstrated by the fact that the degra-
dation rate was not reduced in a Dmpd1 Dmpd2 Deug1
Deps1 strain (Fig. 6 A). Surprisingly, however, substitution
of PDI1 with MPD1, MPD2, or EUG1 also had no signifi-
cant effect on CPY* degradation (Fig. 6 B). To rule out
any possible inconsistencies as compared with the experi-
mental procedures used by Gillece et al. (1999), we tested
the CPY* degradation in a Dpdi1 [PDI1SGHS-CGHC] strain
used by Gillece et al. (1999). Consistent with their find-
Figure 4. Intracellular folding and
maturation of CPY followed by immu-
noprecipitation from pulse-labeled
cells separated on SDS-PAGE. Cells
were labeled for 15 min and chased for
0, 15, and 60 min. (A) A Dpdi1 strain
rescued by the indicated genes. (B)
Comparison of a Dpdi1 and a Dpdi1
Dmpd1 Dmpd2 Deug1 Deps1 strain con-
taining plasmids with PDI1 or MPD1.The Journal of Cell Biology, Volume 152, 2001 560
ings, the rate of CPY* degradation in this strain was sig-
nificantly reduced (data not shown). Based on these ob-
servations, we must conclude that the homologues can
substitute for any putative role played by Pdi1p in the deg-
radation of this substrate.
Discussion
When cysteine residues enter the lumen of the ER as part
of a translocated polypeptide chain, they encounter a
change in the redox environment that ultimately promotes
formation of intrachain and/or interchain disulfide bonds.
In the generally accepted view, PDI is involved in two re-
actions during the oxidative folding of a protein: (a) the in-
troduction of disulfide bonds in a polypeptide substrate by
transfer of a disulfide bond between the two PDI active
site cysteines (i.e., in the oxidized state) to the substrate,
and (b) rearrangement of the incorrect disulfide bonds
that most likely form during complex folding reactions.
The discovery of Ero1p as important for oxidative fold-
ing suggests a pathway for the flow of oxidizing equiva-
lents from yet unknown donors to Ero1p, to the CXXC-
motif of Pdi1p and further to the polypeptide substrate
(Frand and Kaiser, 1999). The present work has demon-
strated that the cell has an absolute requirement for at
least one CXXC-containing PDI. While otherwise wild-
type cells are able to grow if the CGHC-sites of Pdi1p are
exchanged with CGHS, this is not the case if the gene en-
coding the auxiliary CXXC-containing PDI MPD2 is de-
leted. Similarly, EUG1 rescues a pdi1-deleted strain only if
MPD1 and MPD2 both are present, while an Eug1p mu-
tant form containing CXXC active sites can circumvent
the requirement for other CXXC-containing Pdi1p homo-
logues. This also strengthens the notion that the context of
this motif might be of lesser importance (Chivers et al.,
1996). It is remarkable that yeast has evolved a Pdi1p ho-
mologue, Eug1p, with only one cysteine residue in each
active site, rendering it incapable of forming the internal
disulfide bond that is required for oxidation, but suited for
shuffling reactions. The finding that the steady state
proCPY pool in a Dpdi1 [EUG1] strain is partially reduced
(Fig. 5 A) clearly demonstrates the decreased oxidative ca-
pacity of this strain. Frand and Kaiser (1999) propose that
oxidizing equivalents may flow via Pdi1p or Mpd2p to pro-
tein substrates, as shown by cross-linking experiments us-
ing CXXS/A mutant forms. As a Dpdi1 ero1-1 strain is not
rescued by any of the homologues, they must also be de-
pendent on the Ero1p pathway. A weak allele of ERO1
would not affect the ability of the homologues to comple-
ment had they used a different pathway. This is consistent
with the model that Ero1p not only transfers oxidizing
equivalents to Pdi1p and Mpd2p but also to Mpd1p.
As pdi1 deletion is lethal, the question arises as to what
essential cellular process or processes are compromised by
Pdi1p depletion, or, in this case, substitution of Pdi1p with
one of the homologues. We find that mature CPY in some
of our strains migrates differently than CPY in a wild-type
strain, indicating a changed outer chain glycosylation
(Figs. 4 and 5 B). Defects in the ER folding apparatus
could give rise to diminished steady state levels of the en-
zymes involved in glycosylation. Furthermore, these cells
show hypersensitivity to calcofluor white, which is proba-
bly due to cell wall defects. Consistent with this, the mor-
phology of the cells is changed as a consequence of Pdi1p
depletion. It is most prominent in the Dpdi1 [EUG1]
strain, where odd-shaped cells often are encountered.
There are several indications from both yeast and higher
eukaryotes that PDI may be involved in quality control
and degradation of misfolded secretory proteins. How-
ever, we find no effect of deleting the homologues in the
presence of a wild-type copy of PDI1. Likewise, there is
no reduction in the rate of CPY* degradation on substitu-
tion of Pdi1p with any of the homologues Mpd1p, Mpd2p,
or Eug1p (Fig. 6). It therefore appears that neither Pdi1p
nor the homologues play a unique, irreplaceable role in
degradation of CPY*. This is surprising in view of the
previous observation that substitution of Pdi1p with a
Pdi1pSGHS-CGHC mutant form results in significant stabiliza-
tion of CPY* (Gillece et al., 1999). At the present time, we
cannot rationalize these observations. However, it is possi-
ble that a different degradation pathway is invoked under
conditions of severe PDI depletion.
Mpd1p ranks as the most Pdi1p-like of the homologues,
as it can act as the sole PDI in a Dpdi1  Deug1  Dmpd1
Dmpd2 Deps1 strain and, under these conditions, support
an almost normal growth. However, the observation that
expression of PDI1 from the weak MPD1 promoter is suf-
ficient for survival, in conjunction with the multiple de-
fects seen in the pdi1-deleted strains rescued by overex-
Figure 5. Western blot showing the steady state pool of CPY.
(A) A wild-type and a Dpdi1 [EUG1] strain. Cells were lysed in
the presence or absence of 20 mM AMS. In the third lane, the
wild type was treated with 40 mM DTT before lysis and AMS
modification. (B) Western blot showing glycosylation defects of
CPY in a strain with Mpd1p as only PDI source. A wild-type and
a Dpdi1 Deug1 Dmpd1 Dmpd2 Deps1 [MPD1] strain show differ-
ences in the mobility of the various forms of CPY.Nørgaard et al. Yeast PD1 Homologues 561
pressed homologues, demonstrates the superior catalytic
potency of Pdi1p. In the absence of Pdi1p, both Mpd1p
and/or Mpd2p appear to be important contributors to pro-
tein oxidation in the ER. However, MPD1 and MPD2 do
not seem equally well suited to carry out protein oxida-
tion, since MPD2 requires MPD1 to be present to restore
viability of a pdi1-deleted strain. Also, a pdi1-deleted
strain rescued by MPD2 is severely affected in proCPY
folding. The redox potential of the PDI-like protein from
E. coli, DsbA, is strongly dependent on the nature of the
two amino acid residues between the active site cysteines
(Grauschopf et al., 1995). The active site of Mpd1p con-
tains the same sequence as Pdi1p, CGHC, while the active
site of Mpd2p contains the sequence motif CQHC. While
changing this sequence to CGHC did increase the growth
rate of Dpdi1 [MPD2CGHC], the mutation did not enable
the mutant to complement a Dpdi1 Deug1 Dmpd1 Dmpd2
Deps1 strain (data not shown).
In this paper, we have addressed the functionality of the
Pdi1p homologues using an approach that focuses on the
ability of the homologues to replace Pdi1p in various
strain backgrounds. We have seen that there are clear dif-
ferences in the ability of the Pdi1p homologues to ensure
growth when Pdi1p function is compromised, suggesting
different in vivo responsibilities. Some of the genes are
targets of the unfolded protein response (Mori et al.,
1998). Differences in the in vivo function might therefore
include responding to different stress conditions. Cur-
rently, we are investigating the regulation of the genes en-
coding the homologues.
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